This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Folate-modified biomimetic nanovesicles loaded with a PU.1 inhibitor alleviate atherosclerosis by suppressing inflammation
Journal of Nanobiotechnology Open Access 05 December 2025
-
Spatial transcriptomics elucidates localized immune responses in atherosclerotic coronary artery
EMBO Molecular Medicine Open Access 22 August 2025
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Jonasson, L. et al. Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis. J. Clin. Invest. 76, 125–131 (1985)
Related article
Jonasson, L. et al. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 6, 131–138 (1986)
Acknowledgements
M.S. is supported by the British Heart Foundation grant FS/19/56/34893A.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Shoaran, M., Maffia, P. Tackling inflammation in atherosclerosis. Nat Rev Cardiol 21, 442 (2024). https://doi.org/10.1038/s41569-024-01007-z
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41569-024-01007-z
This article is cited by
-
Folate-modified biomimetic nanovesicles loaded with a PU.1 inhibitor alleviate atherosclerosis by suppressing inflammation
Journal of Nanobiotechnology (2025)
-
Spatial transcriptomics elucidates localized immune responses in atherosclerotic coronary artery
EMBO Molecular Medicine (2025)